SCHEMBL7216612

SCHEMBL7216612

COC(=O)C1=Cc2cc(OCc3ccccc3Cl)ccc2S(=O)(=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.43
MAOA P21397 1/20 0.43
NR4A2 P43354 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.40
SLC26A4 O43511 1/20 0.40
KMT2A Q03164 1/20 0.40
HTT P42858 1/20 0.40
SRD5A1 P18405 1/20 0.39
ADAM17 P78536 1/20 0.38
MAPT P10636 5/20 0.38
TDP1 Q9NUW8 1/20 0.38
HDAC8 Q9BY41 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
THRB P10828 1/20 0.37
RORC P51449 1/20 0.36
S1PR5 Q9H228 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7218103 0.89 NR4A2 (0.49) MAOBMAOANR4A2NPC1RAB9A
SCHEMBL7216128 0.88 PARP10 (0.44) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL7218091 0.87 PARP10 (0.37) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL7216505 0.84 NPC1 (0.46) MAOBMAOANR4A2NPC1RAB9A
SCHEMBL7218226 0.83 PARP14 (0.34) MEN1KMT2AMAPTTDP1SMN1; SMN2
SCHEMBL7218151 0.82 PPARD (0.34) MEN1KMT2AHTTMAPTTDP1
SCHEMBL7222605 0.81 MAOB (0.44) MAOBMAOANR4A2HTT
SCHEMBL7222460 0.80 MRGPRX4 (0.47) MAOBNPC1RAB9AADAM17TDP1
SCHEMBL7218066 0.80 NPC1 (0.41) NPC1RAB9AMEN1KMT2AADAM17
SCHEMBL7222083 0.80 MRGPRX4 (0.46) MAOBMAOANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed